Navigation Links
Team AFib™ Unites Patient Advocacy Organizations to Elevate Understanding of Atrial Fibrillation and Stroke
Date:9/7/2011

WASHINGTON, Sept. 7, 2011 /PRNewswire/ -- Team AFib™, a coalition of leading patient advocacy organizations, is unveiling a series of initiatives designed to educate Americans about atrial fibrillation (AFib) and its link to stroke(1) during September's National Atrial Fibrillation Awareness Month. Committed to creating a unified approach to raising awareness about AFib and stroke, Team AFib is made up of National Stroke Association, StopAfib.org, Mended Hearts, Inc., Veterans of Foreign Wars, WomenHeart: The National Coalition for Women with Heart Disease and the National Blood Clot Alliance. Boehringer Ingelheim Pharmaceuticals, Inc., as a leader in the AFib community, is proud to sponsor Team AFib.

Atrial fibrillation is an irregular heartbeat and a common, serious form of heart arrhythmia(1) that impacts more than 2.3 million Americans.(2)  Atrial fibrillation increases the risk of stroke nearly five-fold(3) and strokes associated with AFib can be twice as deadly(4) or disabling as other types of stroke.(5) The good news is this risk can be significantly reduced.(6)

Team AFib's first initiative is an educational video that takes people on a journey through the body of an AFib patient to show how the heart does not beat the way it should, which can result in the formation of blood clots that can travel from the heart to the brain and cause a stroke.(1) The animated experience, called AFib InSight™, can be found online at www.TeamAFib.com and will be featured at the Team AFib booth at health events across the country. Booth visitors can wear goggles that provide a 3D view of the experience and experts will be on hand to answer questions about the condition. Team AFib and the AFib InSight tour will be in Los Angeles, CA for the "Life @50+ AARP National Event & Expo" on Sept. 22-24. Check www.TeamAFib.com for additional tour stops and more information.
'/>"/>

SOURCE Team AFib
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Colorado Association of School Nurses Unites Denver Community to Combat Low Meningitis Vaccination Rates Among Preteens and Teens
2. Unique Cancer Survivors Summit Unites Patients From Across the Nation to Celebrate Life
3. FOX Thanksgiving Day Special Kaleidoscope Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship
4. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
5. Patients Needing Heart Tests Should Talk to Their Doctors About Radiation-Free Diagnostic Options, Including Cardiovascular Ultrasound
6. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
7. NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD® and ResQPump™) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest
8. Skyline Diagnostics and Clavis Pharma to Collaborate on Patient Selection Biomarker Discovery for Leukemia Drug elacytarabine
9. Hurricane Irene Spurs Emergency Home Medical Services for Patients
10. New Drug Approved for Treatment of Non Small Cell Lung Cancer in Specific Patient Population
11. Californians Recognized For Role In Helping Rare Disease Patients Who Need Lifesaving Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Cadence Fitness & Health Center has been ... Fitness Association, a non-profit organization assisting medically integrated health ... Cadence Fitness & Health Center is the only certified ... the Chicagoland area. "The certification means the ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements ... announced tender offer by its indirect wholly-owned subsidiary, Sapphire ... of common stock of Solta Medical, Inc. (NASDAQ: ...
(Date:1/15/2014)...  A novel wearable injector slightly larger than an Oreo cookie ... self-inject prescription drugs in the large doses required to treat ... deficiencies, and genetic disorders.  An emerging biologic ... according to analysts.   Many of these drugs will require a ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
... CAMBRIDGE, Mass., Sept. 21, 2011 IntelligentMDx (IMDx) announced today ... test for the Abbott FDA cleared m 2000 instrument. ... detects and distinguishes the vanA and vanB ... specimens from patients at risk for colonization or infection. Detection ...
... 21, 2011 Mylan Inc. (Nasdaq: MYL ... settlement and license agreement with Hoffman La Roche Inc. ... 500 mg, USP, known generically as Capecitabine Tablets. This ... the treatment of metastatic breast and colorectal cancers. ...
Cached Medicine Technology:IntelligentMDx (IMDx) Introduces a CE-Marked Automated Molecular Test for the Detection of Vancomycin Resistance Genes vanA and vanB Most Commonly Found in Vancomycin-Resistant Enterococci 2Mylan Announces XELODA® Settlement and License Agreement 2
(Date:4/24/2014)... will bring together national experts to discuss solutions ... inaugural Brain Health Summit, titled "The Human Brain: ... Dr. Sandra Bond Chapman, founder and chief director ... Grassley (R-IA), U.S. Representative Chaka Fattah (D-PA) and ... Early Learning, U.S. Department of Education. The day ...
(Date:4/24/2014)... End-of-life aspects, the corresponding terminology, and the relevance ... considered in publications on randomized controlled trials (RCTs). ... the German Institute for Quality and Efficiency in ... as final report. , Together with external experts, ... examples: glioblastoma, lung cancer, malignant melanoma, and pancreatic ...
(Date:4/24/2014)... give than to receive at least if you,re an ... The study found that 15- and 16-year-olds who find pleasure ... members, are less likely to become depressed than those who ... money for themselves. , The researchers detail their findings in ... , The study focused on the ventral striatum, a brain ...
(Date:4/24/2014)... An Oregon State University researcher has found a relationship ... symptoms of autism spectrum disorder in very young children. ... first to show a direct relationship between motor skills ... gross motor skills should be included in treatment plans ... assistant professor in OSU,s College of Public Health and ...
(Date:4/24/2014)... by a scientist at the University of York reveals ... the development of the nervous system may also play ... A research team, led by Dr Will Brackenbury, ... Biology at York, has studied how voltage-gated sodium channels ... are found in the membranes of excitable cells, such ...
Breaking Medicine News(10 mins):Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Study: Altruistic adolescents less likely to become depressed 2Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Breast cancer replicates brain development process 2
... ... University Edwardsville School of Pharmacy has been awarded -- along with the Saint ... (NIH) grant to study ways of relieving chronic pain through new approaches in treating ... ...
... Kimberly-Clark Corporation (NYSE: KMB ) has joined forces ... performance of some of its product packaging. The new ... which benefit schools and communities nationwide. , Kimberly-Clark, ... health, hygiene, and well being, and TerraCycle are now ...
... Life ... , ... 2009 -- Life Care Centers of America recently named Michael Lops as its ... Care, succeeds Sharon Coleman in the position. His appointment is based on “his extensive experience ...
... , MONDAY, Nov. 2 (HealthDay News) -- Though someone ... lack basic knowledge about the potentially life-threatening disease, according ... , Diabetes is responsible for more deaths each year ... combined, but just 42 percent of those surveyed knew ...
... , ROCKVILLE, Md., Nov. 2 Vanda Pharmaceuticals Inc. (Vanda) ... development and commercialization of clinical-stage products for central nervous system ... quarter ended September 30, 2009. , Vanda reported ... of 2009, compared to $12.4 million for the second quarter ...
... , Preliminary evaluation after completion of ... endpoint has been met for patients with advanced-stage, ... Nov. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX: AEZ; ... company focused on endocrine therapy and oncology, today announced ...
Cached Medicine News:Health News:SIUE School of Pharmacy, SLU Pharmacology Receive $975K NIH Grant 2Health News:SIUE School of Pharmacy, SLU Pharmacology Receive $975K NIH Grant 3Health News:SIUE School of Pharmacy, SLU Pharmacology Receive $975K NIH Grant 4Health News:Kimberly-Clark & TerraCycle, Inc. Partner to Reduce Waste and Help Fund Schools and Non-Profits 2Health News:Kimberly-Clark & TerraCycle, Inc. Partner to Reduce Waste and Help Fund Schools and Non-Profits 3Health News:Lops named Life Care's New Chief Compliance Officer 2Health News:Americans Get Failing Grade on Diabetes Awareness 2Health News:Americans Get Failing Grade on Diabetes Awareness 3Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 2Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 3Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 4Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 5Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 6Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 7Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 8Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 9Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 10Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 11Health News:Vanda Pharmaceuticals Reports Third Quarter 2009 Results 12Health News:AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 2Health News:AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 3Health News:AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 4
... for the detection and semi-quantitation of human ... (SLE), Western Equine Encephalitis (WEE), Eastern Equine ... group viruses. Each kit contains ten 8-well ... WEE, EEE, and CE in each well, ...
... immunofluorescent antibody ( RIFA:) test ... of human serum IgM antibodies ... (VCA). Each kit contains ten ... EBV VCA antigen, FITC IgM ...
... immunofluorescent antibody (IFA) test for the ... IgG antibodies to the detection and ... Epstein-Barr virus early antigens, both restricted ... contains ten 12-well slides, FITC conjugate, ...
CMF OL1000 Bone Growth Stimulators are portable, battery-powered medical devices indicated for use in the noninvasive treatment of an established nonunion fracture acquired secondary to trauma, exclu...
Medicine Products: